Literature DB >> 6994764

Acute action of guanfacine on peripheral circulation in hypertensive patients: measurements of arterial flow of the calf and of the forefoot, of venous capacity of the calf, of the blood pressure and of the heart rate.

H Ehringer, G Berger, H Ingerle, U Konecny, A Wöss.   

Abstract

1. The acute action of an intravenous infusion (5 min) of guanfacine in doses of 0.01, 0.02 and 0.04 mg/kg on peripheral circulation was studied in five hypoertensive patients and compared with a placebo in a randomized study. The observations were combined for 2 h after drug administration. 2. Two phases of drug action were seen during and immediately after the administration of guanfacine; a dose-dependent decrease in blood flow mainly of the forefoot but also in the calf was combined with an increase in systolic and diastolic blood pressures and a decrease in heart rate. Peripheral resistance was increased in this phase. Later, an increase in blood flow to the foot combined with a tendency towards a decrease in blood pressure were observed. 3. These preliminary results show that this second phase of action of guanfacine is dependent on the dose given.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994764      PMCID: PMC1430118          DOI: 10.1111/j.1365-2125.1980.tb04917.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  A tandem foream plethysmograph for study of acute responses of the peripheral veins of man: the effect of environmental and local temperature change, and the effect of pooling blood in the extremities.

Authors:  J E WOOD; J W ECKSTEIN
Journal:  J Clin Invest       Date:  1958-01       Impact factor: 14.808

2.  [The effect of raubasine on the vein tonus and venous capacity of the lower leg].

Authors:  H Ehringer; E Deutsch
Journal:  Z Kreislaufforsch       Date:  1968-11

3.  [Differentiated simultaneous blood circulation measurements of consecutive extremity segments (lower leg and foot simultaneously) with an automatically registering venous occlusion plethysmograph: on the question of the occlusion technic].

Authors:  H Ehringer
Journal:  Z Kreislaufforsch       Date:  1969-05

4.  [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].

Authors:  G Grabner; P Michalek; D Pokorny; E Vormittag
Journal:  Arzneimittelforschung       Date:  1966-09

5.  [Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline].

Authors:  K D Bock; V Heimsoth; P Merguet; J Schönermark
Journal:  Dtsch Med Wochenschr       Date:  1966-10-07       Impact factor: 0.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.